You just read:

NeuroVive's new Generation of Sanglifehrin-based Compounds Demonstrate Potent Inhibitory Effects on Human Hepatocellular Cancer Cells

News provided by

NeuroVive Pharmaceutical

Feb 02, 2017, 02:57 ET